DMPI - DelMar Pharmaceuticals Stock Trading

DelMar Pharmaceuticals Inc.(NASDAQ: DMPI) stock trading, description, contact, officers and directors.

About DelMar Pharmaceuticals Inc.

DelMar Pharmaceuticals, Inc. is a clinical and commercial stage drug development company with a focus on the treatment of cancer.

Stock Information

DelMar Pharmaceuticals Inc. Company Name:

DMPI Stock Symbol:

NASDAQ Market:

Get DMPI Alerts

News, Short Squeeze, Breakout and More Instantly...

DMPI - DelMar Announces $19.6 Million Private Placement Priced At-The-Market

SAN DIEGO , Aug. 18, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that it has entered into definitive agreements with investors providing for the sale and issuance of up to 19,587 shares of its Series C Convert...
DMPI - DelMar Announces Approval of Merger by Stockholders

SAN DIEGO , Aug. 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company") announced today that all proposals related to the proposed merger between DelMar and Adgero were approved by DelMar's stockholders at a special meeting held on August 14...
DMPI - DelMar Pharmaceuticals to Host Conference Call to Discuss Proposed Acquisition of Adgero Pharmaceuticals

SAN DIEGO , July 17, 2020 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies announced today that it will be conducting a conference call to discuss...